Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction

Gastric Cancer

Volumn 16, Issue 4, 2013, Pages 590-595

  Goto, Hironobu ^a   Tokunaga, Masanori ^a   Sugisawa, Norihiko ^a   Tanizawa, Yutaka ^a   Bando, Etsuro ^a   Kawamura, Taiichi ^a   Niihara, Masahiro ^a   Tsubosa, Yasuhiro ^a   Terashima, Masanori ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Adenocarcinoma of esophagogastric junction; Gastric cancer; Siewert type II; Splenectomy

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER INCIDENCE; CANCER PATIENT; CHOLECYSTITIS; CLAVIEN DINDO CLASSIFICATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE CLASSIFICATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; INDEX OF ESTIMATED BENEFIT FROM LYMPH NODE DISSECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MORBIDITY; OVERALL SURVIVAL; PANCREAS RELATED COMPLICATION; PLEURA FLUID; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIEWERT TYPE II ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION; SPLENECTOMY; SPLENIC HILAR LYMPH NODE METASTASIS; SURVIVAL RATE; TOTAL STOMACH RESECTION; WOUND COMPLICATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; CARCINOMA, SIGNET RING CELL; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84885952256     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0214-x     Document Type: Article

References (26)

1. Oda I, Abe S, Kusano C, et al. Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas. Gastric Cancer. 2011;14:22-7.
2. Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;11:1662-5.
3. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232:353-61.
4. Biondi A, Hyung WJ. Seventh edition of TNM classification for gastric cancer. J Clin Oncol. 2011;29:4338-9.
5. Suh YS, Han DS, Kong SH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908-15.
6. Okines A, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol. 2010;21(suppl 5):v50-4.
7. Hartgrink H, Jansen E, Grieken N, et al. Gastric cancer. Lancet. 2009;374:477-90.
8. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer. 2010;14:113-23.
9. Katai H, Yoshimura K, Fukagawa T, et al. Risk factors for pancreas-related abscess after total gastrectomy. Gastric Cancer. 2005;8:137-41.
10. Yamashita H, Katai H, Morita S, et al. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg. 2011;254:274-80.
11. Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19:677-83.
12. Sano T, Sasako M, Shibata T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): analyses of operative morbidity, operation time, and blood loss. J Clin Oncol. 2010;28(15 suppl):4020. (ASCO meeting abstract).
13. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101-12.
14. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications. Ann Surg. 2009;250:187-96.
15. Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph-node dissection for gastric cancer. Br J Surg. 1995;82:346-51.
16. Miwa K, Kinami S, Taniguchi K, et al. Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg. 2003;90:178-82.
17. Kobayashi T, Sugimura H, Kimura T. Total gastrectomy is not necessary for advanced gastric cancer of the cardia. Dig Surg. 2002;19:15-21.
18. Cuschieri A, Weeden S, Fielding J. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522-30.
19. Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23:740-80.
20. Kodera Y, Yamamura Y, Shimizu Y, et al. Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma. World J Surg. 1997;21:622-8.
21. Maehara Y, Moriguchi S, Yoshida M, et al. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric cancer. Cancer (Phila). 1991;67:3006-9.
22. Kitamura K, Nishida S, Ichikawa D, et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999;86:119-22.
23. Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 gastrectomy plus splenectomy in 187 patients with gastric cancer. Surgery (St. Louis). 2002;131:401-7.
24. Hartgrink H, Velde C, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol. 2004;22:2069-77.
25. Brady MS, Rogatko A, Dent LL, et al. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg. 1991;126:359-64.
26. Wanebo HJ, Kennedy BJ, Winchester DP, et al. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg. 1997;185:177-84.